276 related articles for article (PubMed ID: 19689919)
1. A model of the economic impact of a bipolar disorder screening program in primary care.
Menzin J; Sussman M; Tafesse E; Duczakowski C; Neumann P; Friedman M
J Clin Psychiatry; 2009 Sep; 70(9):1230-6. PubMed ID: 19689919
[TBL] [Abstract][Full Text] [Related]
2. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.
McCombs JS; Ahn J; Tencer T; Shi L
J Affect Disord; 2007 Jan; 97(1-3):171-9. PubMed ID: 16860396
[TBL] [Abstract][Full Text] [Related]
3. Screening for bipolar disorder in a Spanish sample of outpatients with current major depressive episode.
Tafalla M; Sanchez-Moreno J; Diez T; Vieta E
J Affect Disord; 2009 Apr; 114(1-3):299-304. PubMed ID: 18701169
[TBL] [Abstract][Full Text] [Related]
4. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
5. Long-term effectiveness and cost of a systematic care program for bipolar disorder.
Simon GE; Ludman EJ; Bauer MS; Unützer J; Operskalski B
Arch Gen Psychiatry; 2006 May; 63(5):500-8. PubMed ID: 16651507
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic effects of unrecognized or inadequately treated bipolar disorder.
Keck PE; Kessler RC; Ross R
J Psychiatr Pract; 2008 May; 14 Suppl 2():31-8. PubMed ID: 18677197
[TBL] [Abstract][Full Text] [Related]
7. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a disease management program for major depression in elderly primary care patients.
Bosmans J; de Bruijne M; van Hout H; van Marwijk H; Beekman A; Bouter L; Stalman W; van Tulder M
J Gen Intern Med; 2006 Oct; 21(10):1020-6. PubMed ID: 16836625
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of improving primary care treatment of late-life depression.
Katon WJ; Schoenbaum M; Fan MY; Callahan CM; Williams J; Hunkeler E; Harpole L; Zhou XH; Langston C; Unützer J
Arch Gen Psychiatry; 2005 Dec; 62(12):1313-20. PubMed ID: 16330719
[TBL] [Abstract][Full Text] [Related]
11. A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care.
Sørensen J; Stage KB; Damsbo N; Le Lay A; Hemels ME
Nord J Psychiatry; 2007; 61(2):100-8. PubMed ID: 17454724
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
[TBL] [Abstract][Full Text] [Related]
13. [Bipolarity among unipolar affective disorder patients--uniDEP-BI national multi-site study].
Kiejna A; Rymaszewska J; Hadryś T; Suwalska A; Lojko D; Rybakowski JK
Psychiatr Pol; 2005; 39(5):951-62. PubMed ID: 16358594
[TBL] [Abstract][Full Text] [Related]
14. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care.
Stensland MD; Jacobson JG; Nyhuis A
J Affect Disord; 2007 Aug; 101(1-3):187-93. PubMed ID: 17254637
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
[TBL] [Abstract][Full Text] [Related]
16. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence.
Judd LL; Schettler PJ; Akiskal HS; Coryell W; Leon AC; Maser JD; Solomon DA
Arch Gen Psychiatry; 2008 Apr; 65(4):386-94. PubMed ID: 18391127
[TBL] [Abstract][Full Text] [Related]
17. [Bipolar I disorder in France: prevalence of manic episodes and hospitalisation-related costs].
de Zélicourt M; Dardennes R; Verdoux H; Gandhi G; Papatheodorou ML; Edgell ET; Khoshnood B; Chomette E; Even C; Fagnani F
Encephale; 2003; 29(3 Pt 1):248-53. PubMed ID: 12876549
[TBL] [Abstract][Full Text] [Related]
18. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder.
Hirschfeld RM; Lewis L; Vornik LA
J Clin Psychiatry; 2003 Feb; 64(2):161-74. PubMed ID: 12633125
[TBL] [Abstract][Full Text] [Related]
19. Bipolar mood disorders among Polish psychiatric outpatients treated for major depression.
Rybakowski JK; Suwalska A; Lojko D; Rymaszewska J; Kiejna A
J Affect Disord; 2005 Feb; 84(2-3):141-7. PubMed ID: 15708411
[TBL] [Abstract][Full Text] [Related]
20. Increased medical costs of a population-based sample of depressed elderly patients.
Katon WJ; Lin E; Russo J; Unutzer J
Arch Gen Psychiatry; 2003 Sep; 60(9):897-903. PubMed ID: 12963671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
